Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy
Cell Stem Cell · 2025-02 · 32 (2) · 181-190.e4
DOI: 10.1016/j.stem.2024.11.010 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Cell Stem Cell, 2025-02. Verfasst von Meghan Logun und 15 weiteren Autor:innen. Beteiligte Einrichtung: Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, US…. Hauptthemen laut MEDLINE: Glioblastoma, Organoids, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 126-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Patient-derived tumor organoids have been leveraged for disease modeling and preclinical studies but rarely applied in real time to aid with interpretation of patient treatment responses in clinics. We recently demonstrated early efficacy signals in a first-in-human, phase 1 study of dual-targeting chimeric antigen receptor (CAR)-T cells (EGFR-IL13Rα2 CAR-T cells) in patients with recurrent glioblastoma. Here, we analyzed six sets of patient-derived glioblastoma organoids (GBOs) treated concurrently with the same autologous CAR-T cell products as patients in our phase 1 study. We found that CAR-T cell treatment led to target antigen reduction and cytolysis of tumor cells in GBOs, the degree of which correlated with CAR-T cell engraftment detected in patients' cerebrospinal fluid (CSF). Furthermore, cytokine release patterns in GBOs mirrored those in patient CSF samples over time. Our findings highlight a unique trial design and GBOs as a valuable platform for real-time assessment of CAR-T cell bioactivity and insights into immunotherapy efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of Neurosurgery, University of Pennsylvania Perelman Sch…
- Department of Neuroscience and Mahoney Institute for Neurosciences, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- Neuroscience Graduate Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine,…
- Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, University of Penn…
Förderung
- NINDS NIH HHS
- NCI NIH HHS
- National Institutes of Health
- Dr Miriam and Sheldon G Adelson Medical Research Foundation
- National Institute of Neurological Disorders and Stroke
- Diabetes Research Center, Institute for Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania
- University of Pennsylvania
- Abramson Cancer Center
Zitieren
APA
Logun, M., Wang, X., Sun, Y., Bagley, S. J., Li, N., Desai, A., Zhang, D. Y., Nasrallah, M. P., Pai, E. L., Oner, B. S., Plesa, G., Siegel, D., Binder, Z. A., Ming, G. L., Song, H., & O'Rourke, D. M. (2025). Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy. Cell Stem Cell, 32(2), 181-190.e4. https://doi.org/10.1016/j.stem.2024.11.010
Vancouver
Logun M, Wang X, Sun Y, Bagley SJ, Li N, Desai A, et al. Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy. Cell Stem Cell. 2025;32(2):181-190.e4. doi:10.1016/j.stem.2024.11.010
BibTeX
@article{Logun2025,
author = {Logun, Meghan and Wang, Xin and Sun, Yusha and Bagley, Stephen J and Li, Nannan and Desai, Arati and Zhang, Daniel Y and Nasrallah, MacLean P and Pai, Emily Ling-Lin and Oner, Bike Su and Plesa, Gabriela and Siegel, Donald and Binder, Zev A and Ming, Guo-Li and Song, Hongjun and O'Rourke, Donald M},
title = {Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy},
journal = {Cell Stem Cell},
year = {2025},
volume = {32},
number = {2},
pages = {181--190.e4},
doi = {10.1016/j.stem.2024.11.010}
}
EUVIMED